Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CryptoMedix logo — Pioneering therapeutic advancements in cancer and inflammato...

CryptoMedix

Pioneering therapeutic advancements in cancer and inflammatory diseases by targeting unique collagen epitopes since 2013. Based in Harpswell, Maine.

Founded 2013 Convertible Note Total: $276.50K Biotechnology, Health Care +1

General Information

Company Name CryptoMedix
Founded Year 2013
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Convertible Note
Social

Get notified when CryptoMedix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CryptoMedix

CryptoMedix is a biotechnology startup that has been pioneering therapeutic advancements in cancer and inflammatory diseases since 2013. Headquartered in Harpswell, Maine, the company is focused on the discovery, clinical development, and marketing of therapeutic biologics and diagnostic agents. Their commitment lies in advancing a portfolio of core monoclonal antibodies (mAbs) targeting and inhibiting unique 'cryptic' epitopes of collagen. The startup secured a $276.50KConvertible Note investment on 08 June 2016. CryptoMedix's innovative approach of targeting unique collagen epitopes presents promising opportunities in the biotechnology industry, making it an intriguing prospect for potential venture capital investors.

Taxonomy: Therapeutic advancements, Cancer treatment, Inflammatory diseases, Monoclonal antibodies, Clinical development, Pre-clinical research, Collagen epitopes, Diagnostic agents, Medical research, Maine-based company, Biologics, CryptoMedix LLC, Healthcare innovation, Biopharmaceuticals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• - 08 Jun 2016

CryptoMedix Alternatives & Competitors

CryptoMedix vs
CERES GmbH evaluation & research
CERES GmbH evaluation & research Germany

Your Professional CRO-Team for Medical Devices

11 employees
Design, Manufacturing
CryptoMedix vs
Manipal Acunova
Manipal Acunova

Delivering precision and dedication in clinical research and development globally.

Series B
51-200 employees
Biotechnology
CryptoMedix vs
EVICR.net
EVICR.net Portugal

Dedicated to perform multinational clinical research in ophthalmology with the highest standards of...

3 employees
Health Care, Health and Wellness

FAQ About CryptoMedix

Pioneering therapeutic advancements in cancer and inflammatory diseases by targeting unique collagen epitopes since 2013. Based in Harpswell, Maine.
CryptoMedix was founded in 2013.
CryptoMedix operates in the following industries: Biotechnology, Health Care, Health and Wellness.
CryptoMedix has completed 1 funding round, raising a total of $276.50K. The latest funding stage is Convertible Note.
Top alternatives and competitors to CryptoMedix include CERES GmbH evaluation & research, Manipal Acunova, EVICR.net, Precision For Medicine, Victorem Research. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CryptoMedix and CERES GmbH evaluation & research are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CryptoMedix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy